2971 - 2980 of 9140 Results
Title
Year
-
OPENTitle: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase InhibitionJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 20Issue #: 1Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259Best OA location URL: https://aacrjournals.org/mct/article-pdf/20/1/64/1866868/64.pdfCitation Count: 14
-
OPENTitle: Programming Directional Deep Brain Stimulation in Parkinson’s Disease: A Randomized Prospective Trial Comparing Early versus Delayed Stimulation SteeringJournal Name: Stereotactic and Functional NeurosurgeryPublisher: S. Karger AGVol: 99Issue #: 6Start Page: 484End Page: 490Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000517054Best OA location URL: http://hdl.handle.net/1807/109657Citation Count: 10
- Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease2021OPENTitle: Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s DiseaseJournal Name: European NeurologyPublisher: S. Karger AGVol: 85Issue #: 1Start Page: 24End Page: 30Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000517538Best OA location URL: https://www.karger.com/Article/Pdf/517538Citation Count: 7
-
OPENTitle: A comparative and comprehensive study of prediction of Parkinson’s diseaseJournal Name: Indonesian Journal of Electrical Engineering and Computer SciencePublisher: Institute of Advanced Engineering and ScienceVol: 23Issue #: 3Start Page: 1748End Page: 1748Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.11591/ijeecs.v23.i3.pp1748-1760Best OA location URL: http://ijeecs.iaescore.com/index.php/IJEECS/article/download/25890/15468Citation Count: 3
- Serum peroxiredoxin 3 is reduced in genetic carriers of Parkinson’s disease2022RESTRICTEDTitle: Serum peroxiredoxin 3 is reduced in genetic carriers of Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 250End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2022-329433Citation Count: 3
- Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosis2021OPENTitle: Neurite density explains cortical T1-weighted/T2-weighted ratio in multiple sclerosisJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 92Issue #: 7Start Page: 790End Page: 792Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2020-324391Citation Count: 36
- Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion2022RESTRICTEDTitle: Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversionJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 6Start Page: 659End Page: 667Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2021-328547Citation Count: 94
- Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication response2022OPENTitle: Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication responseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 663Start Page: eadc9669End Page: eadc9669Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adc9669Citation Count: 105
- Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease2022RESTRICTEDTitle: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page: eabj2658End Page: eabj2658Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abj2658Citation Count: 251
-
OPENTitle: Toward preventing Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 818End Page: 819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add7162Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/113804Citation Count: 15